AXON: Iran War Rally Lifts Defense Stock 39%
Axon Enterprise (NASDAQ: AXON) has surged 38.7% in a single week, rocketing from the mid-$400s to $584 as defense stocks caught a powerful bid following the US-Israeli military strikes on Iran. The maker of body cameras, TASER devices, and cloud-based law enforcement software now commands a $47 billion market capitalization — roughly 17 times its trailing twelve-month revenue of $2.78 billion. The rally has narrowed Axon's distance from its 52-week high of $886, though shares still trade well below that peak. With gross margins consistently above 58% and quarterly revenue accelerating from $604 million to $797 million over the past year, the company's fundamentals support a premium — but at a trailing PE of 392, the question is whether even Axon's growth trajectory justifies the current price. Institutional flows confirm the move is more than retail momentum. American Century Companies disclosed a $116 million stake, and Axon appeared alongside Northrop Grumman and RTX among the biggest defense-sector beneficiaries of the geopolitical escalation. For investors watching this name, the interplay between defense spending tailwinds and an extreme valuation multiple is the central tension.